US Patent 11597768 Immunotherapy for hepatocellular carcinoma
Patent 11597768 was granted and assigned to BeiGene, Ltd on March, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11597768 Immunotherapy for hepatocellular carcinoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
